SPARC Intraday Analysis...

SPARC Share Price

Open 311.40 Change Price %
High 316.40 1 Day 3.05 0.98
Low 308.00 1 Week 6.50 2.12
Close 312.95 1 Month 4.20 1.36
Volume 204423 1 Year 15.95 5.37
52 Week High 414.90
52 Week Low 245.20
SPARC Important Levels
Resistance 2 320.74
Resistance 1 317.53
Pivot 312.45
Support 1 308.37
Support 2 305.16
NSE INDIA Most Active Stocks
HDIL 64.60 3.19%
JPASSOCIAT 9.80 -0.51%
NHPC 30.20 3.25%
DLF 129.85 4.63%
SBIN 255.75 1.93%
SUZLON 15.20 1.00%
DHFL 288.00 6.41%
RCOM 31.60 0.80%
JINDALSTEL 78.90 0.57%
HINDALCO 172.60 0.20%
More..
NSE INDIA Top Gainers Stocks
UNIVCABLES 97.80 19.85%
ITDC 301.95 17.13%
DEEPAKFERT 281.15 15.56%
JUBLINDS 375.80 11.43%
WEIZFOREX 188.80 10.93%
20MICRONS 40.20 10.90%
ESL 4.65 10.71%
ESL 4.65 10.71%
ESL 4.65 10.71%
ESL 4.65 10.71%
More..
NSE INDIA Top Losers Stocks
HOTELRUGBY 3.85 -15.38%
BLUECHIP 0.40 -11.11%
REIAGROLTD 0.40 -11.11%
BLBLIMITED 5.90 -6.35%
BILENERGY 0.75 -6.25%
NUTEK 0.75 -6.25%
UNITEDTEA 316.40 -5.96%
UJAAS 43.25 -5.26%
MANAKSTEEL 9.50 -5.00%
PREMIERPOL 32.30 -5.00%
More..

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 3
As on 16th Jan 2017 SPARC Share Price closed @ 312.95 and we RECOMMEND Sell for LONG-TERM with Stoploss of 315.37 & Sell for SHORT-TERM with Stoploss of 313.85 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for January
1st Target up-side 330.96
2nd Target up-side 349.3
3rd Target up-side 367.63
1st Target down-side 278.64
2nd Target down-side 260.3
3rd Target down-side 241.97
SPARC Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.sunpharma.in
SPARC Address
SPARC
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
India
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.